Stuart Therapeutics Completes Phase III Trial for Dry Eye Disease Treatment
ST-100 is a novel approach to dry eye based on a collagen mimetic peptide. Stuart Therapeutics (Florida, United States), a…
ST-100 is a novel approach to dry eye based on a collagen mimetic peptide. Stuart Therapeutics (Florida, United States), a…